This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

Credit: Getty Images Alan Kabat, OD, and Canaan Montgomery, OD, speak to inconsistencies in conjunctivitis treatment protocols between pediatric practices and the influence of parents and school ...

Pink eye, medically known as conjunctivitis, affects millions of Americans each year. This common eye condition can range from mildly irritating to seriously uncomfortable, depending on its cause and ...

Aldeyra Therapeutics has notched up another phase 3 win for its allergic conjunctivitis treatment as the biotech awaits an FDA approval decision for dry eye disease. The INVIGORATE-2 trial enrolled ...

A 10-year study of cultures obtained between 1994 and 2003 from patients with bacterial conjunctivitis found a threefold increase in resistance to ciprofloxacin for gram-positive pathogens (11.7% to ...

Please provide your email address to receive an email when new articles are posted on . Okogen announced completion of $3.3 million in financing to advance the company through its phase 2b clinical ...

DEXTENZA was observed to have a favorable safety profile and be generally well-tolerated in the allergic conjunctivitis as well as the ocular inflammation and pain clinical populations. The most ...

Aldeyra Therapeutics Inc.’s stock ALDX jumped 11% premarket Thursday, after the biotech announced positive results from a late-stage trial of a treatment for allergic conjunctivitis. The Lexington, ...

There are several different common forms of allergic conjunctivitis: seasonal, perennial, vernal, and atopic, in addition to more rare forms. While seasonal allergic conjunctivitis (SAC) does have the ...